Cover Image

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

The enhancer of zeste homolog 2 (EZH2) gene exerts oncogene-like activities and its (over)expression has been linked to several human malignancies. Here, we studied a possible association between EZH2 expression and prognosis in patients with renal cell carcinoma (RCC).

Saved in:
Bibliographic Details
Main Authors: Wagener, Nina (Author) , Macher-Göppinger, Stephan (Author) , Pritsch, Maria (Author) , Hüsing, Johannes (Author) , Hoppe-Seyler, Karin (Author) , Schirmacher, Peter (Author) , Pfitzenmaier, Jesco (Author) , Haferkamp, Axel (Author) , Hoppe-Seyler, Felix (Author) , Hohenfellner, Markus (Author)
Format: Article (Journal)
Language:English
Published: 4 Oct 2010
In: BMC cancer
Year: 2010, Volume: 10, Pages: 1-10
ISSN:1471-2407
DOI:10.1186/1471-2407-10-524
Online Access:Resolving-System, kostenfrei, Volltext: https://doi.org/10.1186/1471-2407-10-524
Verlag, kostenfrei, Volltext: https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-10-524
Get full text
Author Notes:Nina Wagener, Stephan Macher-Goeppinger, Maria Pritsch, Johannes Hüsing, Karin Hoppe-Seyler, Peter Schirmacher, Jesco Pfitzenmaier, Axel Haferkamp, Felix Hoppe-Seyler, Markus Hohenfellner
Description
Summary:The enhancer of zeste homolog 2 (EZH2) gene exerts oncogene-like activities and its (over)expression has been linked to several human malignancies. Here, we studied a possible association between EZH2 expression and prognosis in patients with renal cell carcinoma (RCC).
Item Description:Gesehen am 27.09.2023
Physical Description:Online Resource
ISSN:1471-2407
DOI:10.1186/1471-2407-10-524

Similar Items